KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Esperion Therapeutics (ESPR) Shares Issued (2018 - 2025)

Historic Shares Issued for Esperion Therapeutics (ESPR) over the last 8 years, with Q3 2025 value amounting to $141000.0.

  • Esperion Therapeutics' Shares Issued changed N/A to $141000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $141000.0, marking a year-over-year decrease of 9990.15%. This contributed to the annual value of $90.7 million for FY2024, which is 7294.58% up from last year.
  • Esperion Therapeutics' Shares Issued amounted to $141000.0 in Q3 2025.
  • Esperion Therapeutics' Shares Issued's 5-year high stood at $204.6 million during Q4 2021, with a 5-year trough of $141000.0 in Q3 2025.
  • For the 5-year period, Esperion Therapeutics' Shares Issued averaged around $44.3 million, with its median value being $21.1 million (2022).
  • Data for Esperion Therapeutics' Shares Issued shows a peak YoY increase of 8550125.52% (in 2021) and a maximum YoY decrease of 9550.56% (in 2021) over the last 5 years.
  • Over the past 5 years, Esperion Therapeutics' Shares Issued (Quarter) stood at $204.6 million in 2021, then plummeted by 89.25% to $22.0 million in 2022, then soared by 138.44% to $52.4 million in 2023, then surged by 72.95% to $90.7 million in 2024, then tumbled by 99.84% to $141000.0 in 2025.
  • Its Shares Issued stands at $141000.0 for Q3 2025, versus $90.7 million for Q1 2024 and $52.4 million for Q4 2023.